Cancer Care Center, Inc.

New Albany, Indiana 47150

0 studies enrolling now · 7 studies all time

What they study most

Adenocarcinoma, Chronic Idiopathic Thrombocytopenic Purpura, Chronic Lymphocytic Leukemia, Idiopathic Thrombocytopenic Purpura, Lymphoma, Non-Hodgkin's, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Cancer, Purpura, Thrombocytopenic, Idiopathic, Relapsed Follicular Lymphoma

Studies at this site

• Connect® MM- The Multiple Myeloma Disease Registry — Stopped early
• Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry — Completed
• Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003 — Completed
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) — Completed
• A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma — Completed
• Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma — Completed
• Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas — Stopped early